Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.

Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation. Nuklearmedizin. 2019 Feb 28;: Authors: Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Quick HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K, Vorstand der Interdisziplinären AG für Hybride Bildgebung in alphabetischer Reihenfolge:, Vorstand der Deutschen Röntgengesellschaft (DRG) und der Deutschen Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge: Abstract Combined PET/MR imaging (PET/MRI) was proposed for patient management in 2006 with first commercial versions of integrated whole-body systems becoming available as of 2010. PET/MRI followed the prior evolution of hybrid imaging as attested by the successful adoption of combined PET/CT and SPECT/CT since the early 2000 s. Today, around 150 whole-body PET/MRI systems have become operational worldwide. One of the main application fields of PET/MRI is oncologic imaging. Despite the increasing use of PET/MRI, little governance regarding standardized PET/MRI protocols has been provided to date. Standardization and harmonization of imaging protocols is, however, mandatory for efficient on-site patient management and multi-center studies. This document summarizes consensus recommendations on key aspects of patient referral and preparation, PET/MRI workflow and imaging proto...
Source: Nuklearmedizin - Category: Radiology Authors: Tags: Nuklearmedizin Source Type: research